Lymphoma /

Michael Wang, MD; University of Texas MD Anderson Cancer Center 5Live #ASCO20

8:25

Key Insights on Product characteristics and pharmacological profile of KTE-X19 in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) in the phase II registrational ZUMA-2 trial.

Lymphoma

Key Insights on Product characteristics and pharmacological profile of KTE-X19 in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) in the phase II registrational ZUMA-2 trial.

Lymphoma Similar Videos

Similar Videos

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611

Terms and Conditions | Privacy Policy

Michael Wang, MD; University of Texas MD Anderson Cancer Center 5Live #ASCO20

Lymphoma Similar Videos

IUCLS 2023 Friday General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS

Virtual Challenging Case Clinic: B-cell Lymphomas - CNS Lymphoma_Alvaro Alencar, MD

Virtual Challenging Case Clinic: B-cell Lymphomas_Updates from ASH_Sonali Smith, MD, FASCO

Michael Wang, MD; University of Texas MD Anderson Cancer Center 5Live #ASCO20

Lymphoma Similar Videos

IUCLS 2023 Friday General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS

Virtual Challenging Case Clinic: B-cell Lymphomas - CNS Lymphoma_Alvaro Alencar, MD

Virtual Challenging Case Clinic: B-cell Lymphomas_Updates from ASH_Sonali Smith, MD, FASCO

Share this video

Embed